- 1 June 2018
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 116, 161-172
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cellsFood and Chemical Toxicology, 2013
- Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivoScientific Reports, 2013
- JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like CellsCancer Research, 2013
- STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast CancerJournal of Breast Cancer, 2013
- Mechanisms of Unphosphorylated STAT3 Transcription Factor Binding to DNAJournal of Biological Chemistry, 2012
- Targeting the Interleukin-6/Jak/Stat Pathway in Human MalignanciesJournal of Clinical Oncology, 2012
- Dynamics of the STAT3 Transcription Factor: Nuclear Import Dependent on Ran and Importin-β1PLOS ONE, 2011
- Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 proteinBioorganic & Medicinal Chemistry, 2011
- Silibinin Suppresses Growth of Human Prostate Carcinoma PC-3 Orthotopic Xenograft via Activation of Extracellular Signal-Regulated Kinase 1/2 and Inhibition of Signal Transducers and Activators of Transcription SignalingClinical Cancer Research, 2009
- Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cellsMolecular Cancer Therapeutics, 2008